{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:51:12Z","timestamp":1767912672463,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hereditary Angioedema (HAE) is a genetic disorder that leads to frequent angioedema attacks in various parts of the body. In most cases it is caused by pathogenic variants in the <jats:italic>SERPING1<\/jats:italic> gene, coding for C1-Inhibitor (C1-INH). The pathogenic variants in the gene result in reduced C1-INH levels and\/or activity, which causes aberrant bradykinin production and enhanced vascular permeability. The standard-of-care diagnostic test is performed biochemically via measuring C1-INH level and activity as well as the C4 level. This, however, does not allow for the diagnosis of HAE types with normal C1-INH. There is an urgent need to identify and characterize HAE biomarkers for facilitating diagnostics and personalizing the treatment. The Hereditary Angioedema Kininogen Assay (HAEKA) study aims to measure the dynamics of cleaved High Molecular Weight Kininogen (HKa) and other metabolite levels during the angioedema and non-angioedema state of the disease. The metabolites will be analyzed and verified by liquid chromatography ion mobility high resolution mass spectrometry (LC\/IM-QToF MS) of dried blood spot\u00a0(DBS) cards upon the study completion. The study design is truly innovative: 100 enrolled participants provide blood samples via DBS: (1) every 3\u00a0months within 2\u00a0years during regular study site visits and (2) by at-home self-sampling during HAE attacks via finger pricking. We are presenting a project design that permits clinical study activities during pandemic contact restrictions and opens the door for other clinical studies during COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>As of October 2020, there are 41 patients from 5 sites in Germany enrolled. 90 blood samples were collected during the regular visits, and 19 of the participants also performed self-sampling during the HAE attacks from which a total of 286 attack blood samples were collected. Participating patients rate the study procedures as easy to implement in their daily lives. The concept of home self-sampling is effective, reproducible, and convenient especially in times of contact restrictions due to the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is the hope that the HAEKA study will complete in 2023, reveal biomarker(s) for monitoring HAE disease activity, and may help to avoid HAE attacks via applying medication prior to the symptom onset.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02021-x","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:06:39Z","timestamp":1632855999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HAE patient self-sampling for biomarker establishment"],"prefix":"10.1186","volume":"16","author":[{"given":"Toni M.","family":"F\u00f6rster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Magerl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selen","family":"Z\u00fclbahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Inhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatello","family":"Crocetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volha","family":"Skrahina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"issue":"5","key":"2021_CR1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","volume":"161","author":"A Bygum","year":"2009","unstructured":"Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br JDermatol. 2009;161(5):1153\u20138.","journal-title":"Br JDermatol."},{"key":"2021_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13023-015-0233-x","volume":"10","author":"A Zanichelli","year":"2015","unstructured":"Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M, et al. A nationwide survey of hereditary angioedema due to C1inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015;10:11.","journal-title":"Orphanet J Rare Dis"},{"key":"2021_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1081-1206(10)61121-0","volume":"94","author":"O Roche","year":"2005","unstructured":"Roche O, Blanch A, Caballero T, Sastre N, Callejo D, L\u00f3pez-Trascasa M. Hereditary angio-oedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94:498\u2013503.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"2021_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","volume":"13","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn E, Magerl M, Maetzel A, Maurer M. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis. 2018;13(1):73.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2021_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/humu.23917","volume":"41","author":"D Ponard","year":"2020","unstructured":"Ponard D, Gaboriaud C, Charignon D, Ghannam A, Wagenaar-Bos IGA, Roem D, et al. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes. Hum Mutat. 2020;41(1):38\u201357.","journal-title":"Hum Mutat"},{"issue":"4","key":"2021_CR6","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald G, Bork K. Missense mutations in the coagulation factor XII(Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2021_CR7","doi-asserted-by":"crossref","unstructured":"Bafunno V, Firinu D, D'Apolito M, Cordisco G, Loffredo S, Leccese A, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2017 (in press).","DOI":"10.1016\/j.jaci.2017.05.020"},{"issue":"2","key":"2021_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/all.13270","volume":"73","author":"K Bork","year":"2018","unstructured":"Bork K, Wulff K, Steinm\u00fcller-Magin L, Braenne I, Staubach-Renz P, Witzke G, et al. Hereditary angioedema with a mutation in the plasminogen gene. Allergy. 2018;73(2):442\u201350.","journal-title":"Allergy"},{"key":"2021_CR9","doi-asserted-by":"crossref","unstructured":"Ariano A, D'Apolito M, Bova M, Bellanti F, Loffredo S, D'Andrea G, et al. A myoferlin gain-of-function variant associates with a new type of hereditary angioedema. Allergy. 2020.","DOI":"10.1111\/all.14454"},{"issue":"3","key":"2021_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jaci.2018.01.015","volume":"141","author":"BL Zuraw","year":"2018","unstructured":"Zuraw BL. Hereditary angioedema with normal C1 inhibitor: four types and counting. J Allergy Clin Immunol. 2018;141(3):884\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"2021_CR11","first-page":"00094-4","volume":"S0091-6749","author":"K Bork","year":"2021","unstructured":"Bork K, Wulff K, M\u00f6hl BS, Steinm\u00fcller-Magin L, Witzke G, Hardt J, et al. Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation. J Allergy Clin Immunol. 2021;S0091-6749(21):00094\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2021_CR12","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/all.13384","volume":"73","author":"M Maurer","year":"2018","unstructured":"Maurer M, Magerl M, Ansotegui I, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Betschel S, Bork K, et al. The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018;73(8):1575\u201396.","journal-title":"Allergy"},{"key":"2021_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fmed.2017.00206","volume":"4","author":"AP Kaplan","year":"2017","unstructured":"Kaplan AP, Maas C. The search for biomarkers in hereditary angioedema. Front Med. 2017;4:206.","journal-title":"Front Med"},{"issue":"19","key":"2021_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.4155\/bio-2017-0105","volume":"9","author":"G Zhang","year":"2017","unstructured":"Zhang G, Sexton DJ, Faucette RR, Qiu Y, Wu J. 2D-LC-MS\/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE. Bioanalysis. 2017;9(19):1477\u201391.","journal-title":"Bioanalysis"},{"issue":"12","key":"2021_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/cea.12293","volume":"44","author":"C Suffritti","year":"2014","unstructured":"Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy. 2014;44(12):1503\u201314.","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"2021_CR16","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/ijms20123033","volume":"20","author":"N Hurvitz","year":"2019","unstructured":"Hurvitz N, Dinur T, Becker-Cohen M, Cozma C, Hovakimyan M, Oppermann S, et al. Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease. Int J Mol Sci. 2019;20(12):3033.","journal-title":"Int J Mol Sci"},{"key":"2021_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","volume":"10","author":"A Giese","year":"2015","unstructured":"Giese A, Mascher H, Grittner U, Eichler S, Kramp G, Lukas J, et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis. 2015;10:78.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2021_CR18","doi-asserted-by":"publisher","first-page":"e0157640","DOI":"10.1371\/journal.pone.0157640","volume":"11","author":"C Tanislav","year":"2016","unstructured":"Tanislav C, Guenduez D, Liebetrau C, Giese AK, Eichler S, Sieweke N, et al. Cardiac troponin I: a valuable biomarker indicating the cardiac involvement in fabry disease. PLoS ONE. 2016;11(6):e0157640.","journal-title":"PLoS ONE"},{"issue":"1","key":"2021_CR19","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1038\/s41598-017-06604-2","volume":"7","author":"C Cozma","year":"2017","unstructured":"Cozma C, Iura\u0219cu M, Eichler S, Hovakimyan M, Brandau O, Zielke S, et al. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber disease. Sci Rep. 2017;7(1):6149.","journal-title":"Sci Rep"},{"issue":"4","key":"2021_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000154075","volume":"42","author":"Z Siddique","year":"1992","unstructured":"Siddique Z, McPhaden AR, McCluskey D, Whaley K. A single base deletion from the C1-inhibitor gene causes type I hereditary angio-oedema. Hum Hered. 1992;42(4):231\u20134.","journal-title":"Hum Hered"},{"issue":"2","key":"2021_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/humu.20197","volume":"26","author":"O Roche","year":"2005","unstructured":"Roche O, Blanch A, Duponchel C, Font\u00e1n G, Tosi M, L\u00f3pez-Trascasa M. Hereditary angioedema: the mutation spectrum of SERPING1\/C1NH in a large Spanish cohort. Hum Mutat. 2005;26(2):135\u201344.","journal-title":"Hum Mutat"},{"issue":"3\u20134","key":"2021_CR22","first-page":"181","volume":"121","author":"T G\u00f6sswein","year":"2008","unstructured":"G\u00f6sswein T, Kocot A, Emmert G, Kreuz W, Martinez-Saguer I, Ayg\u00f6ren-P\u00fcrs\u00fcn E, et al. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema. Cytogenet Genome Res. 2008;121(3\u20134):181\u20138.","journal-title":"Cytogenet Genome Res"},{"issue":"2","key":"2021_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jaci.2014.08.007","volume":"135","author":"M Speletas","year":"2015","unstructured":"Speletas M, Szilagyi A, Psarros F, Moldovan D, Magerl M, Kompoti M, et al. Hereditary angioedema: molecular and clinical differences among European populations. J Allergy Clin Immunol. 2015;135(2):570\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000323915","volume":"156","author":"B Kesim","year":"2011","unstructured":"Kesim B, Uyguner ZO, Gelincik A, G\u00f6kmen NM, Sin AZ, Karakaya G, et al. The Turkish Hereditary Angioedema Pilot Study (TURHAPS): the first Turkish series of hereditary angioedema. Int Arch Allergy Immunol. 2011;156(4):443\u201350.","journal-title":"Int Arch Allergy Immunol"},{"issue":"13","key":"2021_CR25","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1016\/j.molimm.2008.05.007","volume":"45","author":"E Pappalardo","year":"2008","unstructured":"Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol. 2008;45(13):3536\u201344.","journal-title":"Mol Immunol"},{"issue":"2","key":"2021_CR26","first-page":"308","volume":"59","author":"E Verpy","year":"1996","unstructured":"Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet. 1996;59(2):308\u201319.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2021_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-017-0604-6","volume":"12","author":"A Aabom","year":"2017","unstructured":"Aabom A, Andersen KE, Fagerberg C, Fisker N, Jakobsen MA, Bygum A. Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema. Orphanet J Rare Dis. 2017;12(1):55.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2021_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9","volume":"17","author":"C Duponchel","year":"2001","unstructured":"Duponchel C, di Rocco C, Cicardi M, Tosi M. Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the C1 inhibitor gene of hereditary angioedema patients. Hum Mutat. 2001;17(1):61\u201370.","journal-title":"Hum Mutat"},{"issue":"6","key":"2021_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/gim.2011.65","volume":"14","author":"S Aradhya","year":"2012","unstructured":"Aradhya S, Lewis R, Bonaga T, Nwokekeh N, Stafford A, Boggs B, et al. Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. Genet Med. 2012;14(6):594\u2013603.","journal-title":"Genet Med"},{"issue":"1","key":"2021_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1073\/pnas.87.1.265","volume":"87","author":"NJ Levy","year":"1990","unstructured":"Levy NJ, Ramesh N, Cicardi M, Harrison RA, Davis AE. Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc Natl Acad Sci USA. 1990;87(1):265\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2021_CR31","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/S0021-9258(18)94031-7","volume":"264","author":"K Skriver","year":"1989","unstructured":"Skriver K, Radziejewska E, Silbermann JA, Donaldson VH, Bock SC. CpG mutations in the reactive site of human C1 inhibitor. J Biol Chem. 1989;264(6):3066\u201371.","journal-title":"J Biol Chem"},{"key":"2021_CR32","unstructured":"Human Gene Mutation Database (HGMD) Professional 2020.1. http:\/\/www.hgmd.org. Qiagen."},{"issue":"14","key":"2021_CR33","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3748\/wjg.v17.i14.1840","volume":"17","author":"J Pichler","year":"2011","unstructured":"Pichler J, Zilbauer M, Torrente F, Heuschkel R, Phillips A, Salvestrini C. Feasibility of a finger prick-based self-testing kit in first- and second-degree relatives of children with coeliac disease. World J Gastroenterol. 2011;17(14):1840\u20133.","journal-title":"World J Gastroenterol"},{"issue":"23","key":"2021_CR34","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1007\/s00216-015-8887-8","volume":"407","author":"M Siebenhaar","year":"2015","unstructured":"Siebenhaar M, K\u00fcllmer K, de Barros Fernandes NM, H\u00fcllen V, Hopf C. Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry. Anal Bioanal Chem. 2015;407(23):7229\u201338.","journal-title":"Anal Bioanal Chem"},{"issue":"Pt 2","key":"2021_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1258\/acb.2008.008147","volume":"46","author":"BG Keevil","year":"2009","unstructured":"Keevil BG, Fildes J, Baynes A, Yonan N. Liquid chromatography-mass spectrometry measurement of tacrolimus in finger-prick samples compared with venous whole blood samples. Ann Clin Biochem. 2009;46(Pt 2):144\u20135.","journal-title":"Ann Clin Biochem"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:24:45Z","timestamp":1632857085000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02021-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to inclusion in the study. The following table gives an overview on the Ethical committees that gave a positive opinion on the conduct of the HAEKA study.Name of Ethical Committee: Sign for HAEKA study; Ethikkommission an der Medizinischen Fakult\u00e4t der Universit\u00e4t Rostock: A 2019-0046; Ethikkommission der Medizinischen Hochschule Hannover: 8825_BO_K_2019; Ethikkommission an der Medizinischen Fakult\u00e4t der Universit\u00e4t Leipzig: 538\/19-lk; Ethikkommission der Universit\u00e4t Ulm: 440\/19; Ethikkommission des Fachbereichs Medizin der Goethe-Universit\u00e4t Frankfurt: 19-511; Ethikkommission der Landes\u00e4rztekammer Rheinland-Pfalz: 2019-14773; Ethikkommission bei der Landes\u00e4rztekammer Hessen: 2020-1512-zvBO; Ethikkommission der \u00c4rztekammer Westfalen-Lippe und der Westf\u00e4lischen Wilhelms-Universit\u00e4t: 2020-469-b-S","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Toni M. F\u00f6rster, Arndt Rolfs, and Volha Skrahina have been during the concept phase and initiation of the study CENTOGENE GmbH employees. Arndt Rolfs has been the founder of CENTOGENE GmbH and holds stock\/stock options in the company. Selen Z\u00fclbahar and Susanne Zielke are CENTOGENE GmbH employees. Marcus Maurer reports personal fees from Alnylam, grants and personal fees from BioCryst, grants from CENTOGENE, grants and personal fees from CSL Behring, grants from Dyax, grants and personal fees from Kalvista, grants from Pharming, personal fees from Pharvaris, grants and personal fees from Shire\/Takeda, outside the submitted work. Markus Magerl is a PI of a center of the HAEKA study. He further reports personal fees and non-financial support from Shire Takeda, personal fees and non-financial support from CSL Behring, personal fees from Pharming, personal fees and non-financial support from Biocryst, personal fees from Kalvista, personal fees from Octapharma, outside the submitted work. Donatello Crocetta is employee of Takeda. Neil Inhaber is employee of Takeda and holds stock\/stock options in Takeda.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}